लोड हो रहा है...

Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments

Since the discovery of camelid heavy-chain antibodies in 1993, there has been tremendous excitement for these antibody domains (VHHs/sdAbs/nanobodies) as research tools, diagnostics, and therapeutics. Commercially, several patents were granted to pioneering research groups in Belgium and the Netherl...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखक: Mehdi Arbabi-Ghahroudi
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI AG 2022-04-01
श्रृंखला:International Journal of Molecular Sciences
विषय:
VHH
ऑनलाइन पहुंच:https://www.mdpi.com/1422-0067/23/9/5009
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!